📰 Johnm Evans News
Page 3 - Johnm Evans News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Johnm Evans. Real-time updates on events, politics, business and more.
May 22, 2023
Sectoral Asset Management Inc. lessened its stake in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) by 3.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 63,500 shares of the company’s stock after selling 2,200 shares during the quarter. Sectoral Asset Management […]
May 15, 2023
Beam Therapeutics (NASDAQ:BEAM – Get Rating) had its price target cut by Royal Bank of Canada from $50.00 to $42.00 in a report issued on Thursday, The Fly reports. BEAM has been the subject of a number of other research reports. William Blair reiterated an outperform rating on shares of Beam Therapeutics in a research […]
May 11, 2023
Beam Therapeutics (NASDAQ:BEAM – Get Rating) had its price objective cut by stock analysts at Royal Bank of Canada from $50.00 to $42.00 in a note issued to investors on Thursday, The Fly reports. Royal Bank of Canada’s target price points to a potential upside of 18.74% from the stock’s previous close. A number of […]
April 15, 2023
Shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) have been assigned an average recommendation of “Moderate Buy” from the eleven analysts that are covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year target price among […]
November 10, 2022
Los Angeles Capital Management LLC raised its holdings in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) by 34.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,496 shares of the company’s stock after purchasing an additional 4,199 shares […]
November 3, 2022
DekaBank Deutsche Girozentrale lessened its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) by 11.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,000 shares of the company’s stock after selling 1,800 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in […]
April 5, 2022
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
December 2, 2021
Investegate announcements from BMO UK High Inc Tst, Half-year Report